You will not be handed a prescription and left to self-manage
The standard retatrutide dose schedule is: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Week 17 onward: 8-12 mg once weekly (maintenance) In the combination context, many researchers find that 8 mg is sufficient for their maintenance dose rather than pushing to 12 mg, because the cagrilintide provides enough additional appetite suppression and satiety to make the extra 4 mg of retatrutide unnecessary
For more information, please visit www.hspharm.com
They are not a substitute for nutrition, resistance training, medical supervision, or long-term planning
Many patients describe feeling satisfied with smaller portion sizes, experiencing reduced cravings for high-calorie or sweet foods, and noticing less frequent hunger between meals
Managing Challenges Managing challenges is about anticipating side effects, social pressures, and the natural highs and lows of treatment so you can establish appropriate expectations and continue progressing
